ProBioGen and Virbac signed Licensing Agreement

Berlin, (PresseBox) -

This release was saved as a PDF file. Please click on the "view PDF" link to display this report.

Display press release

You need the free Adobe Reader in order to display this release.

Download Adobe Reader


ProBioGen AG

ProBioGen is a cell specialist. By combining deep molecular understanding of cells with state-of-the-art industry process engineering and production know-how, ProBioGen's technologies enable biopharmaceutical companies to develop products with superior efficiency, safety and a more favourable cost profile. Since its inception in 1994, the company has processed more than 300 cell lines and established a GMP unit based on disposable reactor technology, which supports all currently available manufacturing processes. The company is headquartered in Berlin.

For more information, please visit www.probiogen.de

Press releases you might also be interested in

Weitere Informationen zum Thema "Forschung und Entwicklung":

Das sind die wichtigsten Techniktrends 2018

In den nächs­ten zehn Jah­ren wer­den fünf Mil­li­ar­den An­wen­der über Hoch­ge­schwin­dig­keits­netz­wer­ke ver­bun­den sein. Ne­ben Men­schen ge­hen auch Bil­lio­nen von Ma­schi­nen ans Netz. Da­mit ein­her geht ei­ne neue Art zu ar­bei­ten. Neue Soft­wa­re treibt die di­gi­ta­le Trans­for­ma­ti­on voran und er­mög­licht im­mer in­tel­li­gen­te­re Un­ter­neh­men.

Weiterlesen

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


I want to subscribe to the gratis press mail and have read and accepted the conditions.